Sanofi
Why Robinhood?
You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!About SNY
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories.
SNY Key Statistics
Stock Snapshot
As of today, Sanofi(SNY) shares are valued at $50.75. The company's market cap stands at 123.81B, with a P/E ratio of 12.35 and a dividend yield of 3.2%.
As of 2025-11-10, Sanofi(SNY) stock has fluctuated between $49.91 and $50.75. The current price stands at $50.75, placing the stock +1.7% above today's low and 0.0% off the high.
The Sanofi(SNY)'s current trading volume is 1.71M, compared to an average daily volume of 2.13M.
In the last year, Sanofi(SNY) shares hit a 52-week high of $60.12 and a 52-week low of $44.62.
In the last year, Sanofi(SNY) shares hit a 52-week high of $60.12 and a 52-week low of $44.62.
SNY News
Novavax (NVAX) made headlines this week after reporting Q3 revenue that surpassed expectations, finalizing the transfer of U.S. marketing rights for its COVID-1...
In November 2025, Novavax completed the transfer of U.S. marketing authorization for its COVID-19 vaccine to Sanofi and reported third quarter results, which in...
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) reported positive data from the late-stage trial, which assessed Dupixent (dupilumab) for treating allergic fu...
More SNY News
(RTTNews) - Sanofi SA (SNY) on Friday announced that the pivotal LIBERTY-AFRS-AIMS phase 3 study of Dupixent, co-developed with Regeneron Pharmaceuticals Inc. (...
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced the presentation of positive results from the pivotal LIBERTY-AFRS-AIMS Phase 3 trial evaluating the...
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average a...
Novavax (NVAX) has completed the transfer of the U.S. marketing authorization for its COVID-19 vaccine, Nuvaxovid to Sanofi (SNY), enabling Sanofi to take full...